Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver T Stirrup

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMC Medical Research Methodology|June 28, 2018
Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection datesOliver T Stirrup, David T Dunn
Statistical Communications in Infectious Diseases|July 26, 2022
Confidence limits for the averted infections ratio estimated via the counterfactual placebo incidence rateDavid T Dunn, Oliver T Stirrup, David V Glidden
Clinical Trials (London, England)|October 23, 2025
Sample size estimation for the averted events ratioDavid T Dunn, Oliver T Stirrup, David V Glidden
The Lancet. HIV|October 31, 2020
A Bayesian averted infection framework for PrEP trials with low numbers of HIV infections: application to the results of the DISCOVER trialDavid V Glidden, Oliver T Stirrup, David T Dunn
Fetal Diagnosis and Therapy|September 14, 2016
Patterns of Second- and Third-Trimester Growth and Discordance in Twin Pregnancy: Analysis of the Southwest Thames Obstetric Research Collaborative (STORK) Multiple Pregnancy CohortOliver T Stirrup, Asma Khalil, Francesco D'Antonio, et al.
BMC Medical Research Methodology|September 17, 2016
Combined models for pre- and post-treatment longitudinal biomarker data: an application to CD4 counts in HIV-patientsOliver T Stirrup, Abdel G Babiker, Andrew J Copas
BMC Medical Research Methodology|June 26, 2023
Interpretation of active-control randomised trials: the case for a new analytical perspective involving averted eventsDavid T Dunn, Oliver T Stirrup, Sheena McCormack, et al.
The Lancet. HIV|June 13, 2018
The averted infections ratio: a novel measure of effectiveness of experimental HIV pre-exposure prophylaxis agentsDavid T Dunn, David V Glidden, Oliver T Stirrup, et al.
Statistics in Medicine|November 12, 2015
Fractional Brownian motion and multivariate-t models for longitudinal biomedical data, with application to CD4 counts in HIV-positive patientsOliver T Stirrup, Abdel G Babiker, James R Carpenter, et al.
Journal of Virus Eradication|November 23, 2019
Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIVOliver T Stirrup, Caroline A Sabin, Andrew N Phillips, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMC Medical Research Methodology|June 28, 2018
Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection datesOliver T Stirrup, David T Dunn
Statistical Communications in Infectious Diseases|July 26, 2022
Confidence limits for the averted infections ratio estimated via the counterfactual placebo incidence rateDavid T Dunn, Oliver T Stirrup, David V Glidden
Clinical Trials (London, England)|October 23, 2025
Sample size estimation for the averted events ratioDavid T Dunn, Oliver T Stirrup, David V Glidden
The Lancet. HIV|October 31, 2020
A Bayesian averted infection framework for PrEP trials with low numbers of HIV infections: application to the results of the DISCOVER trialDavid V Glidden, Oliver T Stirrup, David T Dunn
Fetal Diagnosis and Therapy|September 14, 2016
Patterns of Second- and Third-Trimester Growth and Discordance in Twin Pregnancy: Analysis of the Southwest Thames Obstetric Research Collaborative (STORK) Multiple Pregnancy CohortOliver T Stirrup, Asma Khalil, Francesco D'Antonio, et al.
BMC Medical Research Methodology|September 17, 2016
Combined models for pre- and post-treatment longitudinal biomarker data: an application to CD4 counts in HIV-patientsOliver T Stirrup, Abdel G Babiker, Andrew J Copas
BMC Medical Research Methodology|June 26, 2023
Interpretation of active-control randomised trials: the case for a new analytical perspective involving averted eventsDavid T Dunn, Oliver T Stirrup, Sheena McCormack, et al.
The Lancet. HIV|June 13, 2018
The averted infections ratio: a novel measure of effectiveness of experimental HIV pre-exposure prophylaxis agentsDavid T Dunn, David V Glidden, Oliver T Stirrup, et al.
Statistics in Medicine|November 12, 2015
Fractional Brownian motion and multivariate-t models for longitudinal biomedical data, with application to CD4 counts in HIV-positive patientsOliver T Stirrup, Abdel G Babiker, James R Carpenter, et al.
Journal of Virus Eradication|November 23, 2019
Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIVOliver T Stirrup, Caroline A Sabin, Andrew N Phillips, et al.
Pageof 2